PT-141 Dosage Calculator: Units, Reconstitution, and Chart

A PT-141 dosage calculator is not really a calculator. It is three numbers and two divisions, and the reason people look for one is that the answer changes completely depending on a variable most protocol sheets leave out: how much bacteriostatic water went into the vial.

This page is that calculation written out. Vial strength in, diluent volume in, an exact insulin syringe mark out, with charts for the 5mg and 10mg vials that make up almost the entire research market, and a section on the errors that turn a 1mg dose into a 0.1mg one without anything on the bench looking wrong.

The Three Numbers a PT-141 Calculation Needs

Every unit figure on this page comes from the same three inputs.

• Vial strength. The milligrams of lyophilised peptide stated on the label. PT-141 is sold predominantly as 10mg, with 5mg a common second option.
• Diluent volume. The millilitres of bacteriostatic water added. This is a choice, not a property of the vial, and it is the input that most often goes unrecorded.
• Target dose. The milligrams intended per administration.

The first two produce concentration. Concentration and the third produce a volume, and volume produces a syringe mark. Skipping to a remembered unit number, without the diluent volume that generated it, is where the large errors come from.

The Formula, Written Out Once

First the concentration. Divide vial strength by the water added:

Concentration (mg/ml) = vial strength (mg) ÷ water added (ml)

Then the draw volume. Divide target dose by that concentration:

Draw volume (ml) = target dose (mg) ÷ concentration (mg/ml)

Then the syringe mark. A U-100 insulin syringe puts 100 units across 1ml, so one unit is 0.01ml:

Units = draw volume (ml) × 100

A 10mg vial with 2ml of water is 5mg/ml. A 1mg dose divided by 5mg/ml is 0.2ml, which is 20 units. That is the whole arithmetic, identical in structure to the tesamorelin calculation and to every other reconstituted peptide, which means one habit covers all of them: write the diluent volume on the vial label the moment you add it.

The 1.75mg Reference Point, and Why It Matters Here

PT-141 is bremelanotide, and bremelanotide has an approved form. Vyleesi delivers 1.75mg subcutaneously as a single as-needed dose, taken at least 45 minutes before anticipated activity, with a label maximum of one dose in any 24 hours and eight doses in a month. It reached approval for hypoactive sexual desire disorder in premenopausal women on the back of two phase 3 trials.

That is the only PT-141 number with a regulatory dossier behind it, which makes it the right anchor for a calculation page. It is evidence that 1.75mg is a dose a manufacturer was willing to defend on tolerability and effect. It is not a protocol for a research vial of unverified concentration, drawn by hand rather than delivered by a fixed-volume autoinjector, in a population the trials did not study.

Research protocols in circulation run from roughly 0.5mg to 2mg, so that band brackets the approved dose rather than departing from it, which is unusual in this market. The receptor mechanism and reported effect profile are covered in the PT-141 compound guide.

Worked Chart: 10mg Vial

The 10mg vial is the market standard. All figures assume a U-100 insulin syringe, and the 1.75mg column is included because it is the approved-label dose.

Read across the 1mg column and the point of the page appears. The same 1mg dose is 10 units in the first row and 50 units in the last. Neither is wrong, and both describe 1mg. Anyone who memorises a unit number without the diluent volume attached has memorised nothing transferable, and the figure they carry to the next vial will be wrong by a factor the syringe cannot reveal.

Two millilitres is the choice most protocols settle on for a 10mg vial, and the chart shows why: every common target dose lands on a clean whole-unit mark except 1.75mg, which lands on a readable half unit.

Worked Chart: 5mg Vial

Note that a 5mg vial with 1ml produces the same concentration as a 10mg vial with 2ml, and therefore the same unit marks. Concentration is the only thing the syringe knows about. Vial strength decides how many doses you get, not how far to pull the plunger.

Doses Per Vial, and Why That Sets the Water Volume

PT-141 is dosed as needed rather than on a standing schedule, which makes doses per vial a more useful planning figure here than for a daily compound.

This is where the diluent choice becomes a real decision rather than a preference. Reconstituted PT-141 has a working life measured in weeks under refrigeration, not months, so a 10mg vial divided into twenty 0.5mg doses can easily outlast its own stability window before it is empty. The practical rule is to pick the water volume against how quickly the vial will realistically be used, not against the finest division the syringe can theoretically read. The storage guide covers stability properly, and a degraded vial is worth remembering as a failure mode because it does not announce itself: a dose that stops working is at least as likely to be a storage problem as a tolerance one.

Choosing the Diluent Volume

Water does not change how much peptide is in the vial. It changes how finely it can be divided, and the tradeoff runs both ways.

Too little water

A 10mg vial with 0.5ml sits at 20mg/ml, putting a 1mg dose at 5 units. At that concentration one unit of measurement error is 20 percent of the dose, and the meniscus in an insulin syringe is not readable to better than roughly half a unit in practice.

Too much water

A 10mg vial with 5ml puts a 2mg dose at 100 units, the entire barrel of a standard U-100 syringe. Anything above 2mg then requires two draws, and a 1ml injection volume is more than is comfortable subcutaneously.

The middle

For a 10mg vial, 2ml to 3ml puts common doses between 20 and 60 units. That is the readable middle of the syringe, where a half unit of error is a small fraction of the dose rather than a meaningful one. The handling sequence itself, from swabbing the stopper to directing water down the vial wall rather than onto the powder, is covered in the reconstitution guide, and the diluent choice in the bacteriostatic water guide.

The Errors That Cost a Factor of Ten

Serious PT-141 dosing errors are almost never judgement errors about the target dose. They are arithmetic and labelling errors, and they cluster in four places.

• The unrecorded diluent volume. The single most common one. A vial reconstituted last month with an unremembered volume cannot be dosed from at all, because there is no way to recover the concentration by looking at it. Write the volume and the date on the vial.
• Milligrams read as micrograms. PT-141 doses sit in the sub-milligram to low-milligram range, and a protocol written in mcg beside a vial labelled in mg invites a thousandfold slip. 1mg is 1000mcg. A protocol quoting 500mcg means 0.5mg, not 500mg.
• Assuming the syringe scale is a dose scale. Units are volume. The same 20 unit draw is 0.5mg, 1mg or 2mg depending only on the water. There is no such thing as a correct unit figure for PT-141 in the abstract.
• Carrying a number between vial strengths. Switching from a 10mg vial to a 5mg vial while keeping the same water volume and the same unit mark halves the dose silently. The plunger looks identical in both cases.

None of these are exotic, and all four are prevented by the same habit of writing the diluent volume on the label before the syringe comes out. The injection mechanics themselves are covered in the injection guide.

What the Calculation Cannot Tell You

A calculator produces a number from a label, and assumes the label is accurate. That assumption is the weakest link in the sequence. A vial holding 7mg rather than the 10mg printed on it makes every figure on this page wrong by 30 percent, and no amount of careful syringe reading recovers it. That is the argument for a published batch certificate of analysis rather than a marketing claim about purity.

The calculation also says nothing about whether a dose is advisable. Bremelanotide's approved label carries a transient blood pressure increase after dosing, a contraindication in uncontrolled hypertension and known cardiovascular disease, and nausea as by far the most common adverse effect, reported by a large minority of trial participants. The label cap of eight doses a month is a real constraint derived from the trial programme, not a commercial one. Anyone reading a dosing chart should read the effect and safety profile alongside it rather than instead of it.

Finally, the calculation says nothing about legal status. PT-141 sold as a research chemical is not an approved drug in that form, whatever the approved status of bremelanotide as a finished product. The legal status guide covers what the research use only designation does and does not mean.

Key Takeaways

• Concentration is vial strength divided by water added, and it is the only thing the syringe scale responds to
• Units = (target dose ÷ concentration) × 100 on a U-100 insulin syringe, where one unit is 0.01ml
• A 10mg vial with 2ml gives 5mg/ml, putting 0.5mg at 10 units, 1mg at 20 units and 2mg at 40 units
• A 5mg vial with 1ml gives the same concentration and therefore the same unit marks as a 10mg vial with 2ml
• 1.75mg is the approved bremelanotide dose, capped at one in 24 hours and eight a month, and is the only PT-141 figure with a regulatory dossier behind it
• Pick the diluent volume against how fast the vial will be used, because reconstituted stability is measured in weeks
• Write the diluent volume and date on the vial label, which prevents the majority of large dosing errors on its own
• Every figure here assumes the label is accurate, which is why a batch certificate of analysis matters more than the arithmetic

Frequently Asked Questions

How many units of PT-141 is a 1mg dose?

It depends entirely on how much bacteriostatic water went into the vial, because insulin syringe units measure volume rather than peptide. A 10mg vial reconstituted with 2ml sits at 5mg per ml, which puts 1mg at 20 units on a U-100 syringe. The same 10mg vial reconstituted with 1ml sits at 10mg per ml, which puts 1mg at 10 units. A unit figure carried over from one vial to the next without the diluent volume attached is meaningless.

How do you reconstitute a 10mg PT-141 vial?

Adding 2ml of bacteriostatic water to a 10mg vial gives 5mg per ml, which is a convenient concentration because common research doses land on whole or half unit marks: 0.5mg is 10 units, 1mg is 20 units and 2mg is 40 units. Direct the water down the vial wall rather than onto the powder, and swirl rather than shake. The general handling sequence is covered in the reconstitution guide.

What is the approved dose of bremelanotide?

Vyleesi, the FDA approved bremelanotide autoinjector, delivers 1.75mg subcutaneously as a single as-needed dose at least 45 minutes before anticipated activity, with a label maximum of one dose in 24 hours and eight doses in a month. That 1.75mg figure is the only PT-141 dose number with a regulatory dossier behind it. It is a useful anchor for a calculation page, not a protocol for a research compound of unverified concentration.

How many doses are in a 10mg PT-141 vial?

Ten at 1mg per dose, roughly five to six at the 1.75mg to 2mg end, and twenty at 0.5mg. Reconstituted PT-141 has a working life measured in weeks under refrigeration rather than months, so a vial divided into twenty small doses may outlast its own stability window before it is finished. Diluent volume should be chosen against how quickly the vial will realistically be used.

Why does the same number of units give a different PT-141 dose?

Because the unit markings on an insulin syringe are a volume scale, not a peptide scale. One unit on a U-100 syringe is 0.01ml regardless of what is in the barrel. The dose that volume carries is set by concentration, which is vial strength divided by the water added. Change the water volume and every unit figure on the page changes with it, which is the single most common source of large PT-141 dosing errors.

Can PT-141 be measured in a normal syringe instead of an insulin syringe?

It can be drawn in a 1ml tuberculin syringe graduated in millilitres, and the arithmetic is the same, but the readable resolution is worse. A U-100 insulin syringe divides 1ml into 100 marks across a narrow barrel. A typical tuberculin syringe is wider and harder to read against at the same graduation. For sub-milligram precision at low concentrations, the insulin syringe is the more forgiving instrument.